Etonogestrel

Overview

Etonogestrel is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1531).

API suppliers (6)

Suppliers of Etonogestrel evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• Gedeon Richter Usa1 active DMF
• ASPEN OSS BVNetherlands1 active DMF GMP on record
• STERLING SPAItaly1 active DMF GMP on record
• INDUSTRIALE CHIMICA SRLItaly1 active DMF GMP on record
• CURIA SPAIN SAUSpain1 active DMF GMP on record
• STEROID SPAItaly1 active DMF GMP on record

EU CEP holders (2)

Companies holding a valid EU Certificate of Suitability (CEP) for Etonogestrel, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Etonogestrel expires 28 Jul 2030 and exclusivity 16 Jan 2029. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one

Canonical SMILES

CC[C@]12CC(=C)[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34

InChIKey

GCKFUYQCUCGESZ-BPIQYHPVSA-N